CoChat

Management of depression/anxiety in patients with chronic liver disease

Open access
Garcia-Altieri, Mauro, Carrera-Mejias, Keila, Hernaez, Ruben · 2024 · Clinical Liver Disease

The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index; 24 of the 30 sources its claims cite were checked for support.

Abstract

Export {"href":"Single Video Player","role":"media-player-id","content-type":"play-in-place","position":"float","orientation":"portrait","label":"","caption":"","object-id":[{"pub-id-type":"doi","id":""},{"pub-id-type":"other","content-type":"media-stream-id","id":"1_v7qc37hn"},{"pub-id-type":"other","content-type":"media-source","id":"Kaltura"}]}

Overview

CoChat Summary

TL;DR

This narrative review summarizes the epidemiology, pathophysiology, screening, and pharmacologic management of depression and anxiety in patients with chronic liver disease and cirrhosis. It proposes a patient-centered model of care integrating mental health screening and treatment into hepatology practice.

Key findings

  • Depression and anxiety are common in cirrhosis: approximately 1 in 6 patients with cirrhosis have moderately severe to severe depression, and half have moderate to severe anxiety; in a baseline survey of 1021 patients with compensated cirrhosis across 3 US institutions, self-reported poor health, being widowed, fear of HCC, higher household income, and Hispanic ethnicity were associated with moderately severe to severe depression, while male sex, self-reported poor health, and fear of HCC were associated with high anxiety.
  • Comorbid depression is linked to worse outcomes: diagnosis of cirrhosis nearly doubled the incidence of depression in the first 3 months (incidence rate ratio 1.24 before diagnosis vs 2.12 after, p<0.001), and depression is a stronger predictor of poor adherence to medical treatment.
  • Screening: the authors recommend the Patient Depression Questionnaire-9 and General Anxiety Disorder-7, described as free, patient-administered tools with sensitivity >85% and specificity >76%.
  • Dosing of psychotropics should be guided by Child-Turcotte-Pugh (CTP) class: most CTP-A patients tolerate 75%–100% of a standard initial dose, CTP-B patients may need a 50%–75% reduction, and CTP-C patients require close monitoring. Benzodiazepines should be avoided in patients at risk of HE except for seizures or delirium tremens, where lorazepam, temazepam, or oxazepam are preferred.

Methods

Not stated in the paper (narrative review without a described systematic search strategy, included-study selection, or primary data collection; it synthesizes cited literature and provides two summary tables and three figures). The paper reports cited epidemiologic figures from prior studies (e.g., NHANES 2005–2010 and 2007–2016, US IBM MarketScan 2016, a Korean claims cohort, and a 1021-patient multi-institution cirrhosis survey) rather than conducting its own analysis. Management recommendations are adapted from Menon et al. and other cited sources.

Limitations

The paper states no limitations. Evident from the text: it is a narrative review with no described systematic search or evidence-grading methodology; its treatment recommendations are adapted from other sources rather than derived from primary data; and several cited epidemiologic estimates come from claims databases or cross-sectional surveys, which cannot establish causality.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1097/cld.0000000000000179

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Image 1
From the PDF
FIGURE 1 Factors associated with mood and anxiety disorder presence and development.
FIGURE 1 Factors associated with mood and anxiety disorder presence and development.From the PDF
FIGURE 2 Pathophysiological considerations in patients with different stages of cirrhosis when prescribing medications for depression and anxiety.
FIGURE 2 Pathophysiological considerations in patients with different stages of cirrhosis when prescribing medications for depression and anxiety.From the PDF
FIGURE 3 Models of care in patients with cirrhosis, integrating of mental health services. Abbreviations: ANA, antinuclear antibodies; AUDITC, Alcohol Use Disorders Identification Test; CBC, complete blood count; CBT, cognitive behavioral therapy; CMP, comprehensive metabolic panel; GAD-7, General Anxiety Disorder; INR, International Normalized Ratio; PHQ9, Patient Depression Questionnaire; TSH, thyroid stimulating hormone; UDS, urinary drug screen.
FIGURE 3 Models of care in patients with cirrhosis, integrating of mental health services. Abbreviations: ANA, antinuclear antibodies; AUDITC, Alcohol Use Disorders Identification Test; CBC, complete blood count; CBT, cognitive behavioral therapy; CMP, comprehensive metabolic panel; GAD-7, General Anxiety Disorder; INR, International Normalized Ratio; PHQ9, Patient Depression Questionnaire; TSH, thyroid stimulating hormone; UDS, urinary drug screen.From the PDF

Verification

Claims the paper makes

21 Valid · 1 Not valid · 5 Not checked · 2 Own results and interpretations

7 more claims · 4 with their cited sources checked

Create a free account to see all 29 claims and every source verdict.

See all claims — free account
  • Probably not a substantial claim. 9
  • It may state two separate claims as one. 8
  • Not yet classified. 1

Create a free account to see these claims.

Citations

Cites

Show all 22 references

Cited by

See all 11

Metadata

Authors
Garcia-Altieri, M., Carrera-Mejias, K., & Hernaez, R.
Affiliations
  • Michael E. DeBakey VA Medical Center (US)
  • The University of Texas Southwestern Medical Center (US)
  • Section of Gastroenterology, Michael E. DeBakey Veterans Affairs Medical Center, Houston, Texas, USA
Venue
Clinical Liver Disease
Published
2024-01
Volume
23
Issue
1
Pages
e0179-e0179
ISSN
2046-2484 (ISSN-L)
OpenAlex
W4399451505
Cited by
11
References
21
Citations by year
2026: 5 · 2025: 6
FWCI
2.85
Type
journal article
Language
en
Open access
Locations
  • Clinical Liver Disease (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • Digital Commons-TMC (Texas Medical Center) (submittedVersion)
Funders
U.S. Department of Veterans Affairs
Topics
  • Health Sciences › Medicine › Hepatology › Liver Disease and Transplantation
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
Keywords
depression, anxiety, chronic liver disease, psychiatric comorbidity, mental health management

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-09-28, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-09-28 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Management of depression/anxiety in patients with chronic liver disease. https://app.cochat.ai/papers/10.1097/cld.0000000000000179
The paper
Garcia-Altieri, M., Carrera-Mejias, K., & Hernaez, R. (2024). Management of depression/anxiety in patients with chronic liver disease. Clinical Liver Disease. https://doi.org/10.1097/cld.0000000000000179

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.